Bluegrass Vascular Expands SAVE-US IDE Trial and Completes Enrollment in European Post-market Registry

October 22, 2018

Publication: Endovascular Today

Bluegrass Vascular Technologies has completed enrollment of the prospective, multicenter, international, post–CE Mark approval SAVE registry, which is evaluating the company’s Surfacer system to facilitate access in venous occlusions. The Surfacer system received CE Mark approval in 2016.